Ambient scribe developer Nabla said Brian Manning will be the Paris-based company's new CEO as it looks to grow in a highly ...

Novo Nordisk sued Eli Lilly for allegedly running a “deceptive” ad campaign that uses “outdated clinical trials” to make its ...

A former doctor accused of sexual assault but on the run for 20 years appears to have been living a secret life as a biotech ...

Lax clinical oversight for online GLP-1 prescriptions, proposed financial help for people who want to quit smoking, and more ...

My love for Randy and my professional experience were not enough to save him,” a physician writes about her husband’s suicide ...

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

Lipsitch is the Berberian professor in the Freeman Spogli Institute and the Departments of Medicine and Biology at Stanford University. Cody is the former health officer and director of public health ...

Bristol Myers Squibb is the third drugmaker in nine months to announce it is building the largest AI supercomputer in the ...

Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He ...

The real opportunity is to move beyond policies and narratives that pit specialties against one another,” presidents of the ...

Eighty percent of new Ebola cases in eastern Congo are emerging from unknown chains of transmission, the World Health Organization said Tuesday, a sign the outbreak is spreading faster than health ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...